Effect of plasmapheresis on serum levels of clobazam, levetiracetam and topiramate
Epilepsy & Behavior Case Reports · 2017 · 8 · 66-68
DOI: 10.1016/j.ebcr.2017.07.002 ↗Kurz gefasst
Fallbericht in der Zeitschrift Epilepsy & Behavior Case Reports, 2017. Verfasst von To Harmony Hau Man und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Queen Mary Hospital, Hong Kong. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, Queen Mary Hospital, Hong Kong.
- Division of Neurology, Queen Mary Hospital, Hong Kong.
- Division of Clinical Biochemistry, Department of Pathology and Clinical Biochemistry, Queen Mary Hospital, Hong Kong.
- Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong.
Zitieren
APA
Hau Man, T. H., Shek-Kwan, C. R., On-Kei, C. A., & Lam, C. P. W. (2017). Effect of plasmapheresis on serum levels of clobazam, levetiracetam and topiramate. Epilepsy & Behavior Case Reports, 8, 66-68. https://doi.org/10.1016/j.ebcr.2017.07.002
Vancouver
Hau Man TH, Shek-Kwan CR, On-Kei CA, Lam CPW. Effect of plasmapheresis on serum levels of clobazam, levetiracetam and topiramate. Epilepsy & Behavior Case Reports. 2017;8:66-68. doi:10.1016/j.ebcr.2017.07.002
BibTeX
@article{HauMan2017,
author = {Hau Man, To Harmony and Shek-Kwan, Chang Richard and On-Kei, Chan Angel and Lam, Chan Phoebe Wing},
title = {Effect of plasmapheresis on serum levels of clobazam, levetiracetam and topiramate},
journal = {Epilepsy & Behavior Case Reports},
year = {2017},
volume = {8},
pages = {66--68},
doi = {10.1016/j.ebcr.2017.07.002}
}
EUVIMED